mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |